Formycon CEO Dr. Stefan Glombitza spoke at the Lupus Alpha Investment Focus 2024 about biosimilars and how patients and healthcare systems can benefit from these highly effective and affordable drugs.
News
Pipeline
Career
Formycon AG
The Biosimilar Experts